Jianqing Lin, MD is the co-program leader in urological oncology at the GW Cancer Center and Associate Professor of Medicine at the George Washington University School of Medicine and Health Sciences. The urological oncology multidisciplinary program fosters collaboration among medical oncologists, urologists, radiologists, radiation oncologists, pathologists, population scientists, and basic scientists to enhance clinical and translational research and improve outcomes for urologic cancers.
For more than ten years Lin has served as a mentor and educator for medical students, medical residents and oncology fellows. His professional affiliations include membership in American Society of Clinical Oncology, Society of ImmunoTherapy of Cancer, and the American Association for Cancer Research.
Lin earned his medical degree at Zhejiang Medical University in China and had a research fellowship at Boston Children's Hospital/Harvard Medical School. He completed his Internal Medicine Residency at Carney Hospital, Tufts University School of Medicine and clinical fellowship in Medical Oncology at Johns Hopkins University School of Medicine.
Lin's primary area of clinical expertise is cancer immunotherapy and the latest systemic treatments for prostate, bladder, kidney and testicular cancer, including investigator initiated novel clinical trials. His research focus is cancer epigenetics and immune-biology and immunotherapy of prostate cancer. He serves as an active member in the ECOG-ACRIN Genitourinary committee.